Quantcast

Latest Non-steroidal anti-inflammatory drugs Stories

2014-06-18 08:28:42

NEWARK, Calif., June 18, 2014 /PRNewswire/ -- Depomed, Inc. (NASDAQ:DEPO) today announced that it will be presenting at the JMP Securities 2014 Healthcare Conference in New York City. The presentation at the JMP conference is scheduled for 11:30 am ET (8:30 am PT) on Tuesday June 24, 2014. The presentation will be webcast, and the webcast can be accessed via the Investor Relations page of the Depomed website at www.depomed.com. A recording of the webcast will be archived for 30...

2014-06-10 08:30:40

NEWARK, Calif., June 10, 2014 /PRNewswire/ -- Depomed, Inc. (NASDAQ:DEPO) today announced that it will be presenting at the Wells Fargo 2014 Healthcare Conference in Boston. The presentation at the Wells Fargo conference is scheduled for 3:35 pm ET (12:35 pm PT) on Wednesday June 18, 2014. The presentation will be webcast, and the webcast can be accessed via the Investor Relations page of the Depomed website at www.depomed.com. A recording of the webcast will be archived for 30...

2014-06-06 23:00:28

DeepResearchReports.com adds “2014 Deep Research Report on Global and China Methyl Salicylate Industry” and “2014 Deep Research Report on Global and China Methyl Bromide Industry” reports to its research store. Dallas, Texas (PRWEB) June 07, 2014 "2014 Deep Research Report on Global and China Methyl Salicylate Industry” is a professional and in-depth research report on the Global and China methyl salicylate market. The report provides basic methyl salicylate information,...

2014-06-03 08:28:25

MADISON, Tenn., June 3, 2014 /PRNewswire/ -- More and more athletes seeking optimal performance are saying "no" to non-steroidal anti-inflammatory drugs (NSAIDs) and switching to safe, non-toxic AminoActiv® (http://aminoactiv.com/), which not only relieves pain and inflammation but also adds performance-related benefits. Photo - http://photos.prnewswire.com/prnh/20140602/93454 Photo - http://photos.prnewswire.com/prnh/20140602/93455 Product Manager Don Raymond says that AminoActiv should be...

2014-05-29 08:29:40

MISSISSAUGA, ON, May 29, 2014 /PRNewswire/ - Nuvo Research Inc. (TSX: NRI), a specialty pharmaceutical company with a diverse portfolio of topical and immunology products today announced that a third party has received U.S. Food and Drug Administration (FDA) approval to market and sell a topical diclofenac sodium 1.5% solution in the United States. The product is a generic version of Nuvo's PENNSAID (diclofenac sodium topical solution) 1.5% w/w (PENNSAID 1.5%). Mallinckrodt Inc. (NYSE:MNK)...

FDA Approves Several Drugs That Predictably Increase Risk For Heart And Stroke
2014-05-28 03:41:30

By Jeannette Spalding, Case Western Reserve University The agency charged to protect patients from dangerous drug side effects needs to be far more vigilant when it comes to medications that affect blood pressure. Robert P. Blankfield, MD, MS, a clinical professor of family medicine, issues this call to the U.S. Food and Drug Administration (FDA) in an editorial published recently in an online edition of the Journal of Cardiovascular Pharmacology and Therapeutics; the print version of...

2014-05-27 16:25:31

NEWARK, Calif., May 27, 2014 /PRNewswire/ -- Depomed, Inc. (NASDAQ: DEPO) today announced that it will be presenting at the Jefferies 2014 Global Healthcare Conference in New York City. The presentation at the Jefferies conference is scheduled for 11:00 am ET (8:00 am PT) on Tuesday June 3, 2014. The presentation will be webcast, and the webcast can be accessed via the Investor Relations page of the Depomed website at www.depomed.com. A recording of the webcast will be archived for...

2014-05-15 12:35:20

LONDON, May 15, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Ophthalmic Drugs: World Market Prospects 2013-2023http://www.reportbuyer.com/pharma_healthcare/treatments/eye_care/ophthalmic_drugs_world_market_prospects.html Report DetailsHow to find trends and revenue predictions for the ophthalmic drug industryWhat are the commercial prospects for treating eye disorders? Visiongain's new report gives you forecasted revenues to 2023. It explains trends,...

2014-05-15 08:28:43

MADISON, Tenn., May 15, 2014 /PRNewswire/ -- No matter how diligently one applies sunscreen, summer almost inevitably means sunburns for people who like spending lots of time outdoors. AminoActiv® (http://aminoactiv.com), the #1 alternative to ibuprofen & NSAIDs®, offers relief for painful sunburns with its non-toxic, anti-inflammatory topical cream. Manufactured by Vireo Systems, AminoActiv topical cream and capsules are sold through retailers and at the website's online store. Photo...

2014-05-09 16:24:36

NEWARK, Calif., May 9, 2014 /PRNewswire/ -- Depomed, Inc. (NASDAQ:DEPO) today announced that it will be presenting at two upcoming investor conferences: Bank of America Merrill Lynch Healthcare Conference in Las Vegas Nevada on Thursday May 15 at 11:00 am Eastern Time (8:00 am Pacific Time). UBS Global Healthcare Conference in New York City on Monday May 19 at 9:00 am Eastern Time (6:00 am Pacific Time). The presentations will be webcast, and the webcasts can be accessed via the...


Word of the Day
cacodemon
  • An evil spirit; a devil.
  • A nightmare.
  • In astrology, the twelfth house of a scheme or figure of the heavens: so called from its signifying dreadful things, such as secret enemies, great losses, imprisonment, etc.
'Cacodemon' comes from a Greek term meaning 'evil genius.'
Related